Inflammatory Markers in Mother’s Own Milk and Infant Stool of Very Low Birthweight Infants
Journal of Human Lactation · 2023
DOI: 10.1177/08903344231192441 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Human Lactation, 2023. Verfasst von Rebecca Hoban und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Division of Neonatology, The Hospital for Sick Children, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Milk, Human, Infant, Premature. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR.
Abstract (Originalsprache)
Background
Mother’s breastmilk is the gold standard for feeding preterm infants. Preterm delivery may be precipitated by inflammatory maternal states, but little is known about milk cytokine profiles and how they correlate with markers of infant gut inflammation (i.e., stool calprotectin) in this vulnerable population. Research Aim: To assess cytokines and inflammatory markers in milk from parents of very preterm infants over time as well as correlations between milk and infant’s stool calprotectin.
Method
This is a secondary analysis of milk samples collected during OptiMoM, a triple-blind randomized clinical trial of infants born < 1250 g (NCT02137473). Longitudinally collected samples were analyzed for cytokines, choline, and inflammatory markers (C-reactive protein [CRP], IFN-γ, IL-10, IL-1β, IL-1ra, IL-6, IL-8, TNF-α). Infant stools were collected for longitudinal calprotectin analysis. Generalized estimating equations quantified longitudinal profiles of milk markers and stool calprotectin, their associations, and the correlation between free choline and C-reactive protein over follow-up.
Result
Participants included 92 parents and infants (median weeks of gestation 27.3, median birth weight 845 g, and prevalence of male infants 45%). In all, 212 milk samples and 94 corresponding stool calprotectin levels were collected 1–11 weeks postpartum. C-reactive protein was present in much higher concentrations than other markers, and was highest in Week 1 postpartum. It decreased over time. IL-8 and free choline also changed over time while other markers did not. There was no correlation between any milk markers and stool calprotectin.
Conclusion
Milk from mothers of very preterm infants has detectable inflammatory markers, some of which change over time. Research is needed to determine if infant outcomes are associated with these markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Division of Neonatology, The Hospital for Sick Children, Toronto, ON, Canada.
- Department of Neonatology, Shamir Medical Center, Tel-Aviv University, Israel.
- Rogers Computational Program, Ted Rogers Centre for Heart Research, The Hospital for Sick Children, University Health Network, Toronto, ON, Canada.
- Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
- University of Toronto School of Medicine, Toronto, ON, Canada.
- Department of Paediatrics, Mount Sinai Hospital, Toronto, ON, Canada.
ORCID-Profile: Rebecca Hoban
Förderung
- CIHR
Zitieren
APA
Hoban, R., Nir, H., Somerset, E., Lewis, J., Unger, S., & O'Connor, D. L. (2023). Inflammatory Markers in Mother’s Own Milk and Infant Stool of Very Low Birthweight Infants. Journal of Human Lactation. https://doi.org/10.1177/08903344231192441
Vancouver
Hoban R, Nir H, Somerset E, Lewis J, Unger S, O'Connor DL. Inflammatory Markers in Mother’s Own Milk and Infant Stool of Very Low Birthweight Infants. Journal of Human Lactation. 2023. doi:10.1177/08903344231192441
BibTeX
@article{Hoban2023,
author = {Hoban, Rebecca and Nir, Hadar and Somerset, Emily and Lewis, Jordan and Unger, Sharon and O'Connor, Deborah L},
title = {Inflammatory Markers in Mother’s Own Milk and Infant Stool of Very Low Birthweight Infants},
journal = {Journal of Human Lactation},
year = {2023},
doi = {10.1177/08903344231192441}
}
EUVIMED